Burlington, Canada Clinical Trials

A listing of Burlington, Canada clinical trials actively recruiting patients volunteers.

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Languages supported at study center
Age Group

Male only (6)
Any (28)

Phase 0 (1)
Phase 1 (1)
Phase 1/2 (1)
Phase 2 (3)
Phase 2/3 (2)
Phase 3 (4)
Unknown (22)

Interventional (14)
Observational (8)

Cairo University (2)
Genzyme, a Sanofi Company (2)
Actelion (1)
Amgen (1)
Arcus Biosciences, Inc. (1)
Delta University for Science and Technology (1)
Eli Lilly and Company (1)
Hacettepe University (1)
Hoag Memorial Hospital Presbyterian (1)
Kafrelsheikh University (1)
Mahidol University (1)
Merck Sharp & Dohme LLC (1)
Papworth Hospital NHS Foundation Trust (1)
Poznan University of Medical Sciences (1)
Queen's University (1)
Sanofi (1)
TrialX (1)
University Health Network, Toronto (1)
University of Alberta (1)
University of Bern (1)
University of Jordan (1)
University of Split, School of Medicine (1)
pfizer (1)

No (26)
Yes (8)

Yes (25)
No (9)

English (3)
Australian English (2)
Arabic (1)
Argentinian Spanish (1)
Armenian (1)
Azerbaijani (1)
Brazilian Portuguese (1)
British English (1)
Catalan (1)
Hindi (1)
Italian (1)
Norwegian Bokmål (1)
Spanish (1)
french (1)

Adult (18+) (31)
Pediatric (Under 18) (21)

I am/have/had

I am/have/hadcastration-resistant prostate cancer

I am/have/hadheart disease

I am/have/hadgilbert's syndrome

I am/have/hadleft ventricular end-diastolic pressure

I am/have/hadmyelitis

I am/have/hadventricular septal defects

I am/have/hadmeasurable disease

I am/have/hadcombination therapy

I am/have/hadhemodynamic evaluation

I am/have/hadcombined modality therapy

I am/have/hadanemia

I am/have/hadmultiple sclerosis

I am/have/hadcalcium

I am/have/hadright heart catheterization

I am/have/hadserum calcium

I am/have/hadconnective tissue disease

I am/have/hadimmunoglobulins

I am/have/hadhemophilia

I am/have/hadbone marrow plasma cells

I am/have/hadcardiovascular disease

added new label for I am/have/had

I am looking for

I am looking formacitentan 10 mg

I am looking fordulaglutide

I am looking forAccepts healthy volunteers

I am looking fortirzepatide

I am looking fortaxane

I am looking forfactor ix

I am looking fortestosterone

I am looking forfitusiran

I am looking forVirtual trials

I am looking fordocetaxel

I am looking forOnline studies

I am looking forantiandrogen therapy

I am looking forantiandrogens

I am looking forcalcium

I am looking formacitentan

I am looking forantihemophilic factor

I am looking forenzalutamide

I am looking forimmunoglobulins

added new label for I am looking for

Advanced Filters

Found 33 clinical trials

Multi-country trial
Phase 2
For pediatric ages
For adults
Recruiting in 10s
Interventional Study
For Males
Genetic Disease
Recruiting

Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or B

Primary Objective: To confirm appropriate dose levels of fitusiran when administered to male pediatric participants (ages 1 to <12 years of age) with severe hemophilia A or B Secondary Objective: To characterize the safety and tolerability To characterize the pharmacokinetics (PK)

bethesda assay

haemophilia a

factor ix

severe haemophilia a

fitusiran

Investigational Site Number 1240001

(6.6 away) Contact site

0 views
04 Dec, 2020
+5 other locations

For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Family Medicine
Recruiting

Supporting Family Caregivers of Persons Living With Dementia: Effectiveness and Sustainability of MT4C-In Care

When a person living with dementia moves into a long term care facility, their family members remain involved in their care. They learn new roles and make significant and often stressful adjustments. These caregivers are an at-risk group, and evidence suggests that their mental health may actually worsen after the …

dementia

McMaster University

(7.5 away) Contact site

0 views
16 Feb, 2024
+3 other locations

Multi-country trial
Phase 1
For Seniors
For adults
Recruiting in 100s
Interventional Study
For Males
Family Medicine
Recruiting

Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer

This is a Phase 1b/2, open-label, multicenter platform trial to evaluate the antitumor activity and safety of AB928-based combination therapy in participants with metastatic castrate resistant prostate cancer (mCRPC).

antiandrogen therapy

antiandrogens

castration-resistant prostate cancer

prostatic neoplasm

measurable disease

Juravinski Cancer Center

(6.3 away) Contact site

0 views
16 Feb, 2024
+21 other locations